DA Davidson analyst Matt Summerville raised the firm’s price target on Ametek (AME) to $215 from $210 and keeps a Buy rating on the shares after its Q2 earnings beat. The firm is raising its 2025 and 2026 estimates, reflecting a modest level of initial accretion with respect to FARO Technologies acquisition and continued improvements within Paragon Medical and its automation business, the analyst tells investors in a research note.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AME: